Secreted FGFR3, but not FGFR1, inhibits lens fiber differentiation

被引:0
|
作者
Govindarajan, V [1 ]
Overbeek, PA [1 ]
机构
[1] Baylor Coll Med, Dept Mol & Cellular Biol, Houston, TX 77030 USA
来源
DEVELOPMENT | 2001年 / 128卷 / 09期
关键词
FGF; FGFR1; FGFR3; lens; differentiation; transgenic mice;
D O I
暂无
中图分类号
Q [生物科学];
学科分类号
07 ; 0710 ; 09 ;
摘要
The vertebrate lens has a distinct polarity with cuboidal epithelial cells on the anterior side and differentiated fiber cells on the posterior side. It has been proposed that the anterior-posterior polarity of the lens is imposed by factors present in the ocular media surrounding the lens (aqueous and vitreous humor). The differentiation factors have been hypothesized to be members of the fibroblast growth factor (FGF) family. Though FGFs have been shown to be sufficient for induction of lens differentiation both in vivo and in vitro, they have not been demonstrated to be necessary for endogenous initiation of fiber cell differentiation. To test this possibility, we have generated transgenic mice with ocular expression of secreted self-dimerizing versions of FGFR1 (FR1) and FGFR3 (FR3), Expression of FR3, but not FR1, leads to an expansion of proliferating epithelial cells from the anterior to the posterior side of the lens due to a delay in the initiation of fiber cell differentiation. This delay is most apparent postnatally and correlates with appropriate changes in expression of marker genes including p57(KIP2), Maf and Prox1. Phosphorylation of Erk1 and Erk2 was reduced in the lenses of FR3 mice compared with nontransgenic mice. Though differentiation was delayed in FR3 mice, the lens epithelial cells still retained their intrinsic ability to respond to FGF stimulation. Based on these results we propose that the initiation of lens fiber cell differentiation in mice requires FGF receptor signaling and that one of the lens differentiation signals in the vitreous humor is a ligand for FR3, and is therefore likely to be an FGF or FGF-like factor.
引用
收藏
页码:1617 / 1627
页数:11
相关论文
共 50 条
  • [21] Novel missense variants in FGFR1 and FGFR3 causes short stature in enrolled families from Pakistan
    Mustafa, Saima
    Akhtar, Zafreen
    Asif, Muhammad
    Amjad, Muhammad
    Ijaz, Maryam
    Latif, Muhammad
    Hassan, Mubashir
    Faisal, Muhammad
    Iqbal, Furhan
    META GENE, 2020, 26
  • [22] Genetic Inhibition of FGFR1 in Cartilage at Adult stage Attenuates the Degeneration of Articular Cartilage in FGFR3 disruption mice
    Xie, Yangli
    Xu, Wei
    Huang, Junlan
    Du, Xiaolan
    Zhou, Siru
    Chen, Lin
    Wang, Zuqiang
    JOURNAL OF BONE AND MINERAL RESEARCH, 2014, 29 : S81 - S82
  • [23] Fibroblast growth factor receptor 1 (FGFR1) is over-expressed in benign prostatic hyperplasia whereas FGFR2-IIIc and FGFR3 are not
    Boget, S
    Cereser, C
    Parvaz, P
    Leriche, A
    Revol, A
    EUROPEAN JOURNAL OF ENDOCRINOLOGY, 2001, 145 (03) : 303 - 310
  • [24] Clinical association analysis of ependymomas and pilocytic astrocytomas reveals elevated FGFR3 and FGFR1 expression in aggressive ependymomas
    Lehtinen, Birgitta
    Raita, Annina
    Kesseli, Juha
    Annala, Matti
    Nordfors, Kristiina
    Yli-Harja, Olli
    Zhang, Wei
    Visakorpi, Tapio
    Nykter, Matti
    Haapasalo, Hannu
    Granberg, Kirsi J.
    BMC CANCER, 2017, 17
  • [25] Targetable FGFR3 Fusions and Novel FGFR3 Mutations in Glioma
    Schittenhelm, Jens
    Ziegler, Lukas
    Mittelbronn, Michel
    Capper, David
    Burghardt, Isabel
    Poso, Antti
    Biskup, Saskia
    Skardelly, Marko
    Tabatabal, Ghazaleh
    ONCOLOGY RESEARCH AND TREATMENT, 2020, 43 : 33 - 33
  • [26] Clinical association analysis of ependymomas and pilocytic astrocytomas reveals elevated FGFR3 and FGFR1 expression in aggressive ependymomas
    Birgitta Lehtinen
    Annina Raita
    Juha Kesseli
    Matti Annala
    Kristiina Nordfors
    Olli Yli-Harja
    Wei Zhang
    Tapio Visakorpi
    Matti Nykter
    Hannu Haapasalo
    Kirsi J. Granberg
    BMC Cancer, 17
  • [27] FGFR1/FGFR1 isoforms in prostate cancer progression to metastasis
    Labanca, E.
    Yang, J.
    Shepherd, P.
    Roberts, J.
    Starbuck, M.
    Broom, B.
    Iyer, M.
    Logothetis, C.
    Chinnaiyan, A.
    Navone, N.
    CLINICAL & EXPERIMENTAL METASTASIS, 2019, 36 (02) : 160 - 160
  • [28] FGFR3 is key
    Gemma K. Alderton
    Nature Reviews Cancer, 2009, 9 : 387 - 387
  • [29] DIFFERENTIAL REGULATION OF FIBROBLAST GROWTH FACTOR-3 CONTROLS FGFR1:FGFR3 BALANCE IN CHONDROCYTES AFTER CARTILAGE INJURY
    Khan, S. N.
    Chanalaris, A.
    Vincent, T. L.
    OSTEOARTHRITIS AND CARTILAGE, 2016, 24 : S137 - S137
  • [30] Anti-tumor activity of infigratinib, a potent and selective inhibitor of FGFR1, FGFR2 and FGFR3, in FGFR fusion-positive cholangiocarcinoma and other solid tumors
    Li, Gary
    Krook, Melanie
    Roychowdhury, Sameek
    Avogadri, Francesca
    Ye, Yining
    Moran, Susan
    CANCER RESEARCH, 2019, 79 (13)